In this issue:
- PIRA affects quality of life in people with RRMS
- Severe gastrointestinal adverse events associated with fumaric acid esters
- Trigeminal neuralgia within the disease course of MS
- Hypnosis and mindfulness interventions reduce fatigue in pwMS
- Real-world effectiveness of satralizumab in NMOSD patients in Japan
- High-dose vitamin D in clinically isolated syndrome
- Long-term disability trajectories in MS
- Low natalizumab trough concentrations are associated with reduced JCV seroconversion
- Subcutaneous ocrelizumab in pwMS
- MS prevalence in NZ
Please login below to download this issue (PDF)